Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1993 1
1994 1
1995 4
1997 3
1998 5
1999 3
2000 2
2001 2
2018 1
2020 1
2021 1
2023 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Free PMC article. Clinical Trial.
Sublingual morphine: efficacy reviewed.
Coluzzi PH. Coluzzi PH. J Pain Symptom Manage. 1998 Sep;16(3):184-92. doi: 10.1016/s0885-3924(98)00046-3. J Pain Symptom Manage. 1998. PMID: 9769621 Free article. Review.
Oral patient-controlled analgesia.
Coluzzi PH. Coluzzi PH. Semin Oncol. 1997 Oct;24(5 Suppl 16):S16-35-42. Semin Oncol. 1997. PMID: 9381226 Review. No abstract available.
An institutional commitment to pain management.
Ferrell BR, Dean GE, Grant M, Coluzzi P. Ferrell BR, et al. Among authors: coluzzi p. J Clin Oncol. 1995 Sep;13(9):2158-65. doi: 10.1200/JCO.1995.13.9.2158. J Clin Oncol. 1995. PMID: 7666074
A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC.
Lisberg A, Cummings A, Goldman JW, Bornazyan K, Reese N, Wang T, Coluzzi P, Ledezma B, Mendenhall M, Hunt J, Wolf B, Jones B, Madrigal J, Horton J, Spiegel M, Carroll J, Gukasyan J, Williams T, Sauer L, Wells C, Hardy A, Linares P, Lim C, Ma L, Adame C, Garon EB. Lisberg A, et al. Among authors: coluzzi p. J Thorac Oncol. 2018 Aug;13(8):1138-1145. doi: 10.1016/j.jtho.2018.03.035. Epub 2018 Jun 1. J Thorac Oncol. 2018. PMID: 29874546 Free PMC article. Clinical Trial.
27 results